MHMaki Hirano

Maki Hirano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maki Hirano has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Shinji Naganawa

    Department of Radiology, Nagoya University Graduate School of Medicine, Japan

    2 shared publications
  • Akiko Nishio

    Department of Radiology, Nagoya University School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan

    1 shared publication
  • Hiroko Satake

    Department of Radiology, Nagoya University School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan

    1 shared publication
  • Hiroko Satake

    Department of Radiology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    1 shared publication
  • Hisashi Kawai

    Department of Radiology, Nagoya University School of Medicine, 65 Tsuruma-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan

    1 shared publication
  • Kazuhiro Shimamoto

    Department of Technical Radiology, Nagoya University School of Health Sciences, Nagoya, Aichi, Japan

    1 shared publication

Latest Publications

  • Diffusion-Weighted Imaging of Breast Masses: Comparison of Diagnostic Performance Using Various Apparent Diffusion Coefficient Parameters

    by Maki Hirano, Hiroko Satake, Satoko Ishigaki, Mitsuru Ikeda, Hisashi Kawai, Shinji Naganawa

    OBJECTIVE. The purpose of our study was to assess the utility of the minimum apparent diffusion coefficient (ADC), average ADC, maximum ADC, and ADC difference value and to find optimum ADC parameters for differentiation between benign and malignant lesions in breast diffusion-weighted imaging (DWI). MATERIALS AND METHODS. Sixty-seven women with 75 masslike lesions (27 benign, 48 malignant) were examined with 3-T MRI. To assess heterogeneity within the lesion, the difference between minimum and maximum ADCs was recorded as the ADC difference value. Diagnostic performances of these parameters were compared by receiver operating characteristic (ROC) curve analysis. RESULTS. Each ADC parameter showed significant differences between malignant and benign lesions. The optimal cutoff levels for differentiating benign versus malignant lesions were determined by identifying the points where the sensitivity and specificity were equal on the ROC curves. According to ROC analyses, the following sensitivities and spec...


  • Predictive Value for Malignancy of Suspicious Breast Masses of BI-RADS Categories 4 and 5 Using Ultrasound Elastography and MR Diffusion-Weighted Imaging

    by Hiroko Satake, Akiko Nishio, Mitsuru Ikeda, Satoko Ishigaki, Kazuhiro Shimamoto, Maki Hirano, Shinji Naganawa

    The aim of this study is to evaluate the ability of ultrasound elastography and MR diffusion-weighted imaging (DWI) to predict malignancy of breast masses, with subsequent recommendation for biopsy. For 115 breast masses classified as BI-RADS category 4 or 5, which were assessed according to combined findings of mammography, B-mode sonography, and dynamic contrast-enhanced MRI, two radiologists retrospectively evaluated the elasticity scores using ultrasound elastography and the apparent diffusion coefficient (ADC) values using MR DWI. The diagnostic abilities of these two techniques were analyzed by using univariate and multivariate logistic regression analysis. In the analysis of all 115 breast masses, the elasticity score was predictive of malignancy, whereas the ADC value was not independently predictive. In an analysis of the 52 masses assessed as BI-RADS category 4, the elasticity score was found to be a significant predictor of malignancy, compared with the ADC value, which was a nonsignificant predictor. In an analysis of the 63 masses assessed as BI-RADS category 5, neither the elasticity score nor the ADC value was a significant predictor of malignancy. Our results show that elasticity imaging provides relatively reliable predictions for malignancy, especially in BI-RADS category 4 masses, compared with MR DWI.